As antibiotic resistance continues to grow worldwide, researchers are exploring plant-derived compounds as potential new antibacterial tools. This pilot study investigated whether cannabidiol (CBD) and cannabinoid-based preparations could inhibit clinical strains of Enterococcus faecalis and Enterococcus faecium, two bacteria commonly associated with hospital-acquired infections and known for developing resistance to conventional antibiotics. Scientists compared purified […]
Category: CBD
CBG and CBD May Interact Differently Within the Body’s Detoxification Pathways (Pub. May 2026)
As research into hemp-derived cannabinoids continues to expand, scientists are learning that cannabinoids like CBD and CBG may affect the body in very different ways. In the study “Cannabigerol and cannabidiol differ in their ability to affect the AhR/CYP1A pathway in vitro,” researchers explored how these two cannabinoids interact with biological pathways connected to detoxification […]
Liposomal CBD Nanoformulation Shows Potential to Reduce HIV Activity and Oxidative Stress in Brain Cells (Pub. March 2026)
HIV can persist in the brain by infecting microglia, a type of immune cell, contributing to chronic inflammation and cognitive complications known as HIV-associated neurocognitive disorders. In this study, researchers investigated whether a liposomal nanoformulation of cannabidiol (CBD) could improve how CBD is delivered to brain cells and enhance its biological effects. Liposomes are tiny […]